FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileInvesco Biotechnology & Genome ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PBE
Invesco Biotechnology & Genome ETF ETF AnalysisComprehensive ETF analysis for Invesco Biotechnology & Genome ETF (PBE) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisPBE
PBE
Invesco Biotechnology & Genome ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
PBE
  1. Home
  2. Screener
  3. Invesco Biotechnology & Genome ETFPBEETF

Invesco Biotechnology & Genome ETF

ETF
🇺🇸PBE•AMEX•Equity
Fund size (USD)
$438.02M
Expense Ratio
0.59%
Yield (12 mo)
1.44%
Holdings
31

Your view on PBE

Invesco Biotechnology & Genome ETF

ETFInvesco
🇺🇸PBE•AMEX•Equity
Fund size (USD)
$438.02M
Expense Ratio
0.59%
Yield (12 mo)
1.44%
Holdings
31
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Invesco Biotechnology & Genome ETF (PBE) is an Equity fund from Invesco, listed since 2005, with $438.0M in assets under management, a 0.59% expense ratio and a NAV of $99.55 USD.

Overview for Invesco Biotechnology & Genome ETF

Fund Type
ETF
Fund Issuer
Invesco
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 23, 2005
Domicile
US
Website
invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html
Fund Type
ETF
Fund Issuer
Invesco
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 23, 2005
Domicile
US
Website
invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html
Fund Type
ETF
Fund Issuer
Invesco
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 23, 2005
Domicile
US
Website
invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html

About this fund

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thor…

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.59%

Yield (12 mo)

1.44%

Fund size

$438.02M

Fund Details

NAV$99.55 USD
Holdings31
Average Volume25.2K
Inception DateJune 23, 2005
Asset ClassEquity
Fund IssuerInvesco
DomicileUS
ISINUS46137V7872
CUSIP46137V787
NAV CurrencyUSD

Expense Ratio

0.59%

Dividend Yield (TTM)

1.44%

Assets Under Management

$438.02M

NAV

$99.55 USD

Holdings

31

Average Volume

25.2K

Inception Date

June 23, 2005

Asset Class

Equity

Fund Issuer

Invesco

Domicile

US

ISIN

US46137V7872

CUSIP

46137V787

NAV Currency

USD

Expense Ratio

0.59%

Dividend Yield (TTM)

1.44%

Assets Under Management

$438.02M

NAV

$99.55 USD

Holdings

31

Average Volume

25.2K

Inception Date

June 23, 2005

Asset Class

Equity

Fund Issuer

Invesco

Domicile

US

ISIN

US46137V7872

CUSIP

46137V787

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 21, 2026Sep 25, 2026$0.0187
Jun 22, 2026Jun 26, 2026$0.8106
Mar 23, 2026Mar 27, 2026$0.0824
Dec 22, 2025Dec 26, 2025$0.4197
Total, 12 months$1.33 a share

Dividend yield (TTM) 1.44% = $1.33 paid per share in the 12 months to Nov 20, 2026 ÷ the $92.59 price. Past distributions; future payments can differ.

Data last updated: Nov 12, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

33 positions
1BIIBBiogen Inc
5.86%
2GILDGilead Sciences Inc
5.86%
3REGNRegeneron Pharmaceuticals Inc
5.79%
4RPRXRoyalty Pharma PLC
5.71%
5AMGNAmgen Inc
5.19%
6VRTXVertex Pharmaceuticals Inc
4.93%
7ILMNIllumina Inc
4.67%
8NTRANatera Inc
4.50%
9VCELVericel Corp
3.85%
10MRNAModerna Inc
3.58%
11TGTXTG Therapeutics Inc
3.34%
12EXELExelixis Inc
3.31%
13QGENQIAGEN NV
3.24%
14UTHRUnited Therapeutics Corp
3.08%
15NBIXNeurocrine Biosciences Inc
2.91%

Concentration

Top 10 Weight49.93%
1BIIBBiogen Inc
5.86%
2GILDGilead Sciences Inc
5.86%
3REGNRegeneron Pharmaceuticals Inc
5.79%
4RPRXRoyalty Pharma PLC
5.71%
5AMGNAmgen Inc
5.19%
6VRTXVertex Pharmaceuticals Inc
4.93%
7ILMNIllumina Inc
4.67%
8NTRANatera Inc
4.50%
9VCELVericel Corp
3.85%
10MRNAModerna Inc
3.58%
11TGTXTG Therapeutics Inc
3.34%
12EXELExelixis Inc
3.31%
13QGENQIAGEN NV
3.24%
14UTHRUnited Therapeutics Corp
3.08%
15NBIXNeurocrine Biosciences Inc
2.91%

Top 10 Weight

49.93%

1BIIBBiogen Inc
5.86%$24.47M
2GILDGilead Sciences Inc
5.86%$24.47M
3REGNRegeneron Pharmaceuticals Inc
5.79%$24.21M
4RPRXRoyalty Pharma PLC
5.71%$23.85M
5AMGNAmgen Inc
5.19%$21.69M
6VRTXVertex Pharmaceuticals Inc
4.93%$20.58M
7ILMNIllumina Inc
4.67%$19.49M
8NTRANatera Inc
4.50%$18.82M
9VCELVericel Corp
3.85%$16.07M
10MRNAModerna Inc
3.58%$14.96M
11TGTXTG Therapeutics Inc
3.34%$13.96M
12EXELExelixis Inc
3.31%$13.84M
13QGENQIAGEN NV
3.24%$13.56M
14UTHRUnited Therapeutics Corp
3.08%$12.86M
15NBIXNeurocrine Biosciences Inc
2.91%$12.17M

Top 10 Weight

49.93%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
PBEInvesco Biotechnology & Genome ETFThis fundEquity0.59%$438M31

Comparable funds

  • AVSDAvantis Responsible International Equity ETFEquity0.23%$379M2,060
  • CLSEConvergence Long/Short Equity ETFEquity1.52%$950M356
  • DEXCDimensional - Emerging Markets ex China Core Equity ETFEmerging Markets Equity0.56%$267M3,506
  • EDOWFirst Trust Dow 30 Equal Weight ETFLarge Cap Equity0.50%$329M30
  • IQSINYLI Candriam International Equity ETFEquity0.15%$253M593
  • ISMDInspire Small/Mid Cap ETFEquity0.53%$331M11
  • JSMLJanus Henderson Small Cap Growth Alpha ETFEquity0.30%$379M121
  • RSPDInvesco S&P 500 Equal Weight Consumer Discretionary ETFEquity0.40%$289M48

More Invesco ETFs

  • DIVGInvesco S&P 500 High Dividend Growers ETFEquity0.39%$12M101
  • DJDInvesco Dow Jones Industrial Average Dividend ETFEquity0.07%$546M29
  • DWASInvesco Dorsey Wright SmallCap Momentum ETFEquity0.60%$376M201
  • EELVInvesco S&P Emerging Markets Low Volatility ETFEquity0.29%$428M202
  • EEMOInvesco S&P Emerging Markets Momentum ETFEquity0.29%$29M202
  • EFAAInvesco MSCI EAFE Income Advantage ETFEquity0.42%$678M675
  • EQALInvesco Russell 1000 Equal Weight ETFEquity0.20%$816M1,011
  • EQWLInvesco S&P 100 Equal Weight ETFEquity0.30%$2.7B102
  • ERTHInvesco MSCI Sustainable Future ETFEquity0.68%$121M177
  • EVMTInvesco Electric Vehicle Metals Commodity Strategy No K-1 ETFAlternatives0.74%$4M2
  • FDIQInvesco Bloomberg Financial Data Providers ETFEquity0.35%$42M32
  • FXAInvesco CurrencyShares Australian Dollar TrustAlternatives0.40%$92M0
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.